Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.

< BACK TO ARCHIVE


2023 Jan 06


PLoS Negl Trop Dis


http://www.ncbi.nlm.nih.gov/pubmed/36608155?dopt=Abstract


17


1

Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.

Authors

Clinical markers of post-Chikungunya chronic inflammatory joint disease: A Brazilian cohort.
Lázari C D S, Ramundo M S, Ten-Caten F, Bressan CS, Bispo de Filippis A M, Manuli E R, de Moraes I, Pereira G M, Côrtes M F, da Candido D S, Gerber AL, Guimarães A P, Faria N R, Nakaya HI, Vasconcelos A TR, Brasil P, Paranhos-Baccalà G, Sabino E C
PLoS Negl Trop Dis. 2023 Jan 06; 17(1):e0011037.
PMID: 36608155.

Abstract

Chikungunya-fever (CHIKF) remains a public health major issue. It is clinically divided into three phases: acute, post-acute and chronic. Chronic cases correspond to 25-40% individuals and, though most of them are characterized by long-lasting arthralgia alone, many of them exhibit persistent or recurrent inflammatory signs that define post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD). We aimed to identify early clinical markers of evolution to pCHIKV-CIJD during acute and post-acute phases.
Read This Paper